| Literature DB >> 26053496 |
Riku Katainen1, Kashyap Dave2, Esa Pitkänen1, Kimmo Palin1, Teemu Kivioja3, Niko Välimäki1, Alexandra E Gylfe1, Heikki Ristolainen1, Ulrika A Hänninen1, Tatiana Cajuso1, Johanna Kondelin1, Tomas Tanskanen1, Jukka-Pekka Mecklin4, Heikki Järvinen5, Laura Renkonen-Sinisalo6, Anna Lepistö5, Eevi Kaasinen1, Outi Kilpivaara1, Sari Tuupanen1, Martin Enge2, Jussi Taipale7, Lauri A Aaltonen1.
Abstract
Cohesin is present in almost all active enhancer regions, where it is associated with transcription factors. Cohesin frequently colocalizes with CTCF (CCCTC-binding factor), affecting genomic stability, expression and epigenetic homeostasis. Cohesin subunits are mutated in cancer, but CTCF/cohesin-binding sites (CBSs) in DNA have not been examined for mutations. Here we report frequent mutations at CBSs in cancers displaying a mutational signature where mutations in A•T base pairs predominate. Integration of whole-genome sequencing data from 213 colorectal cancer (CRC) samples and chromatin immunoprecipitation sequencing (ChIP-exo) data identified frequent point mutations at CBSs. In contrast, CRCs showing an ultramutator phenotype caused by defects in the exonuclease domain of DNA polymerase ɛ (POLE) displayed significantly fewer mutations at and adjacent to CBSs. Analysis of public data showed that multiple cancer types accumulate CBS mutations. CBSs are a major mutational hotspot in the noncoding cancer genome.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26053496 DOI: 10.1038/ng.3335
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330